These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 18327209)
1. Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior. Cheng JX; Tretiakova M; Gong C; Mandal S; Krausz T; Taxy JB Mod Pathol; 2008 Jun; 21(6):647-52. PubMed ID: 18327209 [TBL] [Abstract][Full Text] [Related]
2. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Sigauke E; Rakheja D; Maddox DL; Hladik CL; White CL; Timmons CF; Raisanen J Mod Pathol; 2006 May; 19(5):717-25. PubMed ID: 16528370 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of hSNF5/INI1 distinguishes renal and extra-renal malignant rhabdoid tumors from other pediatric soft tissue tumors. Hoot AC; Russo P; Judkins AR; Perlman EJ; Biegel JA Am J Surg Pathol; 2004 Nov; 28(11):1485-91. PubMed ID: 15489652 [TBL] [Abstract][Full Text] [Related]
5. INI1 expression is retained in composite rhabdoid tumors, including rhabdoid meningiomas. Perry A; Fuller CE; Judkins AR; Dehner LP; Biegel JA Mod Pathol; 2005 Jul; 18(7):951-8. PubMed ID: 15761491 [TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype. Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089 [TBL] [Abstract][Full Text] [Related]
7. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635 [TBL] [Abstract][Full Text] [Related]
8. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pawel BR Pediatr Dev Pathol; 2018; 21(1):6-28. PubMed ID: 29280680 [TBL] [Abstract][Full Text] [Related]
9. ERG and SALL4 expressions in SMARCB1/INI1-deficient tumors: a useful tool for distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Kohashi K; Yamada Y; Hotokebuchi Y; Yamamoto H; Taguchi T; Iwamoto Y; Oda Y Hum Pathol; 2015 Feb; 46(2):225-30. PubMed ID: 25479928 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic undifferentiated rhabdoid carcinoma: KRAS alterations and SMARCB1 expression status define two subtypes. Agaimy A; Haller F; Frohnauer J; Schaefer IM; Ströbel P; Hartmann A; Stoehr R; Klöppel G Mod Pathol; 2015 Feb; 28(2):248-60. PubMed ID: 25103069 [TBL] [Abstract][Full Text] [Related]
11. Pathology and diagnosis of SMARCB1-deficient tumors. Margol AS; Judkins AR Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033 [TBL] [Abstract][Full Text] [Related]
12. Reduced expression of SMARCB1/INI1 protein in synovial sarcoma. Kohashi K; Oda Y; Yamamoto H; Tamiya S; Matono H; Iwamoto Y; Taguchi T; Tsuneyoshi M Mod Pathol; 2010 Jul; 23(7):981-90. PubMed ID: 20305614 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical validation of INI1/SMARCB1 in a spectrum of musculoskeletal tumors: an experience at a Tertiary Cancer Referral Centre. Rekhi B; Jambhekar NA Pathol Res Pract; 2013 Dec; 209(12):758-66. PubMed ID: 24075062 [TBL] [Abstract][Full Text] [Related]
15. A unique pattern of INI1 immunohistochemistry distinguishes synovial sarcoma from its histologic mimics. Arnold MA; Arnold CA; Li G; Chae U; El-Etriby R; Lee CC; Tsokos M Hum Pathol; 2013 May; 44(5):881-7. PubMed ID: 23245672 [TBL] [Abstract][Full Text] [Related]
16. INI1-deficient tumors: diagnostic features and molecular genetics. Hollmann TJ; Hornick JL Am J Surg Pathol; 2011 Oct; 35(10):e47-63. PubMed ID: 21934399 [TBL] [Abstract][Full Text] [Related]
17. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049 [TBL] [Abstract][Full Text] [Related]
18. Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviour. Wu X; Dagar V; Algar E; Muscat A; Bandopadhayay P; Ashley D; Wo Chow C Pathology; 2008 Dec; 40(7):664-70. PubMed ID: 18985520 [TBL] [Abstract][Full Text] [Related]
19. Sarcomatoid renal cell carcinoma with rhabdoid features. Al-Saidi NA; Akhtar M Ann Saudi Med; 2013; 33(5):495-9. PubMed ID: 24188946 [TBL] [Abstract][Full Text] [Related]
20. Rhabdoid tumors: integrating biological insights with clinical success: a report from the SMARCB1 and Rhabdoid Tumor Symposium, Paris, December 12-14, 2013. Bourdeaut F; Chi SN; Frühwald MC Cancer Genet; 2014 Sep; 207(9):346-51. PubMed ID: 25468731 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]